From Nasdaq: 2025-05-14 17:10:00

MDxHealth SA (MDXH) reported a quarterly loss of $0.19 per share, missing the Zacks Consensus Estimate of a loss of $0.13. The company’s revenues of $24.29 million exceeded expectations by 0.76%. The stock has underperformed this year, but future performance will depend on earnings outlook and industry trends.

The company has surpassed consensus EPS estimates only once in the last four quarters. MDxHealth SA’s earnings outlook is mixed, with a Zacks Rank #3 (Hold) currently. Investors should monitor estimate revisions and industry performance for potential impact on the stock’s performance. P3 Health Partners Inc. (PIII) is yet to report results for the quarter.

For investors considering MDxHealth SA (MDXH), it’s important to analyze the company’s earnings outlook and industry trends. Zacks Investment Research offers tools and reports to help investors make informed decisions. The Zacks Rank stock-rating system has a strong track record of outperforming the market. Get the latest recommendations and stock analysis reports from Zacks Investment Research.



Read more at Nasdaq: MDxHealth SA (MDXH) Reports Q1 Loss, Tops Revenue Estimates